PSS for CARIN Consumer-facing Real-time Pharmacy Benefit Check
1b. Project ID
1543
1c. Is Your Project an Investigative Project (aka PSS-Lite)?
No
1d. Is your Project Artifact being Reaffirmed or proceeding to Normative directly after being either Informative or STU?
No
1e. Today's Date
1f. Name of standard being reaffirmed
1g. Project Artifact Information
1h. ISO/IEC Standard to Adopt
1i. Does the standard include excerpted text from one or more ISO, IEC or ISO/IEC standards, but is not an identical or modified adoption?
1j. Unit of Measure
2a. Primary/Sponsor WG
Payer/Provider Information Exchange
2b. Co-Sponsor WG
Health Care Devices
2c. Co-Sponsor Level of Involvement
Request formal content review prior to ballot
2c. Co-Sponsor Update Periods
Periodic updates between meetings during interim calls and at WGMs
2d. Project Facilitator
Pooja Babbrah, Jean Duteau
2e. Other Interested Parties (and roles)
2f. Modeling Facilitator
2g. Publishing Facilitator
Pooja Babrah, Paul Knapp
2h. Vocabulary Facilitator
Tim McNeil
2i. Domain Expert Representative
2j. Business Requirements Analyst
2k. Conformance Facilitator
Pooja Babbrah
2l. Other Facilitators
2m. Implementers
Humana, Cambia
3a. Project Scope
Develop a FHIR R4 based implementation guide for an API similar to the NCPDP Real-Time Pharmacy Benefit Check B2B standard that will allow consumers access to the same information as their providers including information related to their cash price. This information includes formulary and benefit information, OOP costs, therapeutic alternatives, and cash price through an API that would be accessible by the consumer through a third-party application.
Attachments
3b. Project Need
The final Medicare Part D rule for 2020 (https://www.cms.gov/newsroom/fact-sheets/medicare-advantage-and-part-d-drug-pricing-final-rule-cms-4180-f#_Prohibition_Against_Gag) requires all Medicare Part D plans to send members information on lower cost therapeutic alternatives and requires the implementation of a real-time pharmacy benefit tool by 2021.
3c. Security Risk
No
3d. External Drivers
Final Medicare Part D rule for 2020
3e. Objectives/Deliverables and Target Dates
A FHIR R4 Implementation Guide
The desired ballot is January 2020.
Rough timeline
8/2019 - Draft implementation guide published
9/2019 - Connectathon
10/2019 - Development and Connectathon outcomes documented and presented to Pharmacy Work Group
11/2019 - Ballot material approved by Pharmacy Work Group
1/2020 - Ballot
3k. Additional Backwards Compatibility Information (if applicable)
3l. Using Current V3 Data Types?
N/A
3l. Reason for not using current V3 data types?
3m. External Vocabularies
Yes
3n. List of Vocabularies
NCPDP
Additional vocabularies to be added here
3o. Earliest prior release and/or version to which the compatibility applies
None
4a. Products
FHIR Extensions, FHIR Profiles, FHIR Resources
4b. For FHIR IGs and FHIR Profiles, what product version(s) will the profiles apply to?
R4
4c. FHIR Profiles Version
R4
4d. Please define your New Product Definition
4d. Please define your New Product Family
5a. Project Intent
Implementation Guide (IG) will be created/modified
5a. White Paper Type
5a. Is the project adopting/endorsing an externally developed IG?
No
5a. Externally developed IG is to be (select one)
5a. Specify external organization
CARIN Alliance
5a. Revising Current Standard Info
5b. Project Ballot Type
STU to Normative
5c. Additional Ballot Info
January 2020 is the desired ballot date.
5d. Joint Copyright
Yes
5e. I understand I must submit a Joint Copyright Letter of Agreement to the TSC in order for the PSS to receive TSC approval.
no
6a. External Project Collaboration
CARIN Alliance
6b. Content Already Developed
0%
6c. Content externally developed?
No
6d. List Developers of Externally Developed Content
6e. Is this a hosted (externally funded) project?
Yes
6f. Stakeholders
Regulatory Agency, Standards Development Organizations (SDOs), Payors, Other
6f. Other Stakeholders
NCPDP, Consumer
6g. Vendors
Pharmaceutical, Health Care IT
6g. Other Vendors
6h. Providers
Healthcare Institutions (hospitals, long term care, home care, mental health)
6h. Other Providers
6i. Realm
U.S. Realm Specific
7d. US Realm Approval Date
Jun 18, 2019
7a. Management Group(s) to Review PSS
FHIR
7b. Sponsoring WG Approval Date
Jun 24, 2019
7c. Co-Sponsor Approval Date
Jul 02, 2019
7c. Co-Sponsor 2 Approval Date
7c. Co-Sponsor 3 Approval Date
7c. Co-Sponsor 4 Approval Date
7c. Co-Sponsor 5 Approval Date
7c. Co-Sponsor 6 Approval Date
7c. Co-Sponsor 7 Approval Date
7c. Co-Sponsor 8 Approval Date
7c. Co-Sponsor 9 Approval Date
7c. Co-Sponsor 10 Approval Date
7e. CDA MG Approval Date
7f. FMG Approval Date
May 29, 2019
7g. V2 MG Approval Date
7h. Architecture Review Board Approval Date
7i. Steering Division Approval Date
Jul 24, 2019
7j. TSC Approval Date
Sep 09, 2019
Show Changes
Version
6
Modifier
Anne Wizauer
Modify Date
Sep 10, 2019 18:44
1a. Project Name
PSS for CARIN Consumer-facing Real-time Pharmacy Benefit Check
1b. Project ID
1543
1c. Is Your Project an Investigative Project (aka PSS-Lite)?
No
1d. Is your Project Artifact now proceeding to Normative directly or after being either Informative or STU?
No
2a. Primary/Sponsor WG
Pharmacy
2b. Co-Sponsor WG
Health Care Devices
2c. Co-Sponsor Level of Involvement
Request formal content review prior to ballot
2c. Co-Sponsor Update Periods
Periodic updates between meetings during interim calls and at WGMs
2d. Project Facilitator
Pooja Babbrah, Jean Duteau
2g. Publishing Facilitator
Pooja Babrah, Paul Knapp
2h. Vocabulary Facilitator
Tim McNeil
2k. Conformance Facilitator
Pooja Babbrah
2m. Implementers
Humana, Cambia
3a. Project Scope
Develop a FHIR R4 based implementation guide for an API similar to the NCPDP Real-Time Pharmacy Benefit Check B2B standard that will allow consumers access to the same information as their providers including information related to their cash price. This information includes formulary and benefit information, OOP costs, therapeutic alternatives, and cash price through an API that would be accessible by the consumer through a third-party application.
3b. Project Need
The final Medicare Part D rule for 2020 (https://www.cms.gov/newsroom/fact-sheets/medicare-advantage-and-part-d-drug-pricing-final-rule-cms-4180-f#_Prohibition_Against_Gag) requires all Medicare Part D plans to send members information on lower cost therapeutic alternatives and requires the implementation of a real-time pharmacy benefit tool by 2021.
3c. Security Risk
No
3d. External Drivers
Final Medicare Part D rule for 2020
3e. Objectives/Deliverables and Target Dates
A FHIR R4 Implementation Guide
The desired ballot is January 2020.
Rough timeline
8/2019 - Draft implementation guide published
9/2019 - Connectathon
10/2019 - Development and Connectathon outcomes documented and presented to Pharmacy Work Group
11/2019 - Ballot material approved by Pharmacy Work Group
1/2020 - Ballot
3o. Earliest prior release and/or version to which the compatibility applies
None
4a. Products
FHIR Extensions, FHIR Profiles, FHIR Resources
4b. For FHIR IGs and FHIR Profiles, what product version(s) will the profiles apply to?
R4
4c. FHIR Profiles Version
R4
5a. Project Intent
Implementation Guide (IG) will be created/modified
5a. Is the project adopting/endorsing an externally developed IG?
No
5a. Specify external organization
CARIN Alliance
5b. Project Ballot Type
STU to Normative
5c. Additional Ballot Info
January 2020 is the desired ballot date.
5d. Joint Copyright
Yes
6a. External Project Collaboration
CARIN Alliance
6b. Content Already Developed
0%
6c. Content externally developed?
No
6e. Is this a hosted (externally funded) project?
Yes
6f. Stakeholders
Regulatory Agency, Standards Development Organizations (SDOs), Payors, Other
6f. Other Stakeholders
NCPDP, Consumer
6g. Vendors
Pharmaceutical, Health Care IT
6h. Providers
Healthcare Institutions (hospitals, long term care, home care, mental health)
6i. Realm
U.S. Realm Specific
7a. Management Group(s) to Review PSS
FHIR
7b. Sponsoring WG Approval Date
Jun 24, 2019
7c. Co-Sponsor Approval Date
Jul 02, 2019
7d. US Realm Approval Date
Jun 18, 2019
7f. FMG Approval Date
May 29, 2019
7i. Steering Division Approval Date
Jul 24, 2019
7j. TSC Approval Date
Sep 09, 2019
Version
5
Modifier
Anne Wizauer
Modify Date
Sep 06, 2019 20:09
1a. Project Name
PSS for CARIN Consumer-facing Real-time Pharmacy Benefit Check
1b. Project ID
1543
1c. Is Your Project an Investigative Project (aka PSS-Lite)?
No
1d. Is your Project Artifact now proceeding to Normative directly or after being either Informative or STU?
No
2a. Primary/Sponsor WG
Pharmacy
2b. Co-Sponsor WG
Health Care Devices
2c. Co-Sponsor Level of Involvement
Request formal content review prior to ballot
2c. Co-Sponsor Update Periods
Periodic updates between meetings during interim calls and at WGMs
2d. Project Facilitator
Pooja Babbrah, Jean Duteau
2g. Publishing Facilitator
Pooja Babrah, Paul Knapp
2h. Vocabulary Facilitator
Tim McNeil
2k. Conformance Facilitator
Pooja Babbrah
2m. Implementers
Humana, Cambia
3a. Project Scope
Develop a FHIR R4 based implementation guide for an API similar to the NCPDP Real-Time Pharmacy Benefit Check B2B standard that will allow consumers access to the same information as their providers including information related to their cash price. This information includes formulary and benefit information, OOP costs, therapeutic alternatives, and cash price through an API that would be accessible by the consumer through a third-party application.
3b. Project Need
The final Medicare Part D rule for 2020 (https://www.cms.gov/newsroom/fact-sheets/medicare-advantage-and-part-d-drug-pricing-final-rule-cms-4180-f#_Prohibition_Against_Gag) requires all Medicare Part D plans to send members information on lower cost therapeutic alternatives and requires the implementation of a real-time pharmacy benefit tool by 2021.
3c. Security Risk
No
3d. External Drivers
Final Medicare Part D rule for 2020
3e. Objectives/Deliverables and Target Dates
A FHIR R4 Implementation Guide
The desired ballot is January 2020.
Rough timeline
8/2019 - Draft implementation guide published
9/2019 - Connectathon
10/2019 - Development and Connectathon outcomes documented and presented to Pharmacy Work Group
11/2019 - Ballot material approved by Pharmacy Work Group
1/2020 - Ballot
3o. Earliest prior release and/or version to which the compatibility applies
None
4a. Products
FHIR Extensions, FHIR Profiles, FHIR Resources
4b. For FHIR IGs and FHIR Profiles, what product version(s) will the profiles apply to?
R4
4c. FHIR Profiles Version
R4
5a. Project Intent
Implementation Guide (IG) will be created/modified
5a. Is the project adopting/endorsing an externally developed IG?
No
5a. Specify external organization
CARIN Alliance
5b. Project Ballot Type
STU to Normative
5c. Additional Ballot Info
January 2020 is the desired ballot date.
5d. Joint Copyright
Yes
6a. External Project Collaboration
CARIN Alliance
6b. Content Already Developed
0%
6c. Content externally developed?
No
6e. Is this a hosted (externally funded) project?
Yes
6f. Stakeholders
Regulatory Agency, Standards Development Organizations (SDOs), Payors, Other
6f. Other Stakeholders
NCPDP, Consumer
6g. Vendors
Pharmaceutical, Health Care IT
6h. Providers
Healthcare Institutions (hospitals, long term care, home care, mental health)
6i. Realm
U.S. Realm Specific
7a. Management Group(s) to Review PSS
FHIR
7b. Sponsoring WG Approval Date
Jun 24, 2019
7c. Co-Sponsor Approval Date
Jul 02, 2019
7d. US Realm Approval Date
Jun 18, 2019
7f. FMG Approval Date
May 29, 2019
7i. Steering Division Approval Date
Jul 24, 2019
Version
4
Modifier
Anne Wizauer
Modify Date
Aug 27, 2019 18:34
1a. Project Name
PSS for CARIN Consumer-facing Real-time Pharmacy Benefit Check
1b. Project ID
1543
1c. Is Your Project an Investigative Project (aka PSS-Lite)?
No
1d. Is your Project Artifact now proceeding to Normative directly or after being either Informative or STU?
No
2a. Primary/Sponsor WG
Pharmacy
2b. Co-Sponsor WG
Health Care Devices
2c. Co-Sponsor Level of Involvement
Request formal content review prior to ballot
2c. Co-Sponsor Update Periods
Periodic updates between meetings during interim calls and at WGMs
2d. Project Facilitator
Pooja Babbrah, Ryan Howells
2g. Publishing Facilitator
Pooja Babrah, Paul Knapp
2h. Vocabulary Facilitator
Tim McNeil
2k. Conformance Facilitator
Pooja Babbrah
2m. Implementers
Humana, Cambia
3a. Project Scope
Develop a FHIR R4 based implementation guide for an API similar to the NCPDP Real-Time Pharmacy Benefit Check B2B standard that will allow consumers access to the same information as their providers including information related to their cash price. This information includes formulary and benefit information, OOP costs, therapeutic alternatives, and cash price through an API that would be accessible by the consumer through a third-party application.
3b. Project Need
The final Medicare Part D rule for 2020 (https://www.cms.gov/newsroom/fact-sheets/medicare-advantage-and-part-d-drug-pricing-final-rule-cms-4180-f#_Prohibition_Against_Gag) requires all Medicare Part D plans to send members information on lower cost therapeutic alternatives and requires the implementation of a real-time pharmacy benefit tool by 2021.
3c. Security Risk
No
3d. External Drivers
Final Medicare Part D rule for 2020
3e. Objectives/Deliverables and Target Dates
A FHIR R4 Implementation Guide
The desired ballot is January 2020.
Rough timeline
8/2019 - Draft implementation guide published
9/2019 - Connectathon
10/2019 - Development and Connectathon outcomes documented and presented to Pharmacy Work Group
11/2019 - Ballot material approved by Pharmacy Work Group
1/2020 - Ballot
3o. Earliest prior release and/or version to which the compatibility applies
None
4a. Products
FHIR Extensions, FHIR Profiles, FHIR Resources
4b. For FHIR IGs and FHIR Profiles, what product version(s) will the profiles apply to?
R4
4c. FHIR Profiles Version
R4
5a. Project Intent
Implementation Guide (IG) will be created/modified
5a. Is the project adopting/endorsing an externally developed IG?
No
5a. Specify external organization
CARIN Alliance
5b. Project Ballot Type
STU to Normative
5c. Additional Ballot Info
January 2020 is the desired ballot date.
5d. Joint Copyright
Yes
6a. External Project Collaboration
CARIN Alliance
6b. Content Already Developed
0%
6c. Content externally developed?
No
6e. Is this a hosted (externally funded) project?
Yes
6f. Stakeholders
Regulatory Agency, Standards Development Organizations (SDOs), Payors, Other
6f. Other Stakeholders
NCPDP, Consumer
6g. Vendors
Pharmaceutical, Health Care IT
6h. Providers
Healthcare Institutions (hospitals, long term care, home care, mental health)
6i. Realm
U.S. Realm Specific
7a. Management Group(s) to Review PSS
FHIR
7b. Sponsoring WG Approval Date
Jun 24, 2019
7c. Co-Sponsor Approval Date
Jul 02, 2019
7d. US Realm Approval Date
Jun 18, 2019
7f. FMG Approval Date
May 29, 2019
7i. Steering Division Approval Date
Jul 24, 2019
Version
3
Modifier
Ken McCaslin
Modify Date
Aug 20, 2019 23:51
1a. Project Name
PSS for CARIN Consumer-facing Real-time Pharmacy Benefit Check
1b. Project ID
1543
1c. Is Your Project an Investigative Project (aka PSS-Lite)?
No
1d. Is your Project Artifact now proceeding to Normative directly or after being either Informative or STU?
No
2a. Primary/Sponsor WG
Pharmacy
2b. Co-Sponsor WG
Health Care Devices
2c. Co-Sponsor Level of Involvement
Request formal content review prior to ballot
2c. Co-Sponsor Update Periods
Periodic updates between meetings during interim calls and at WGMs
2d. Project Facilitator
Pooja Babbrah, Ryan Howells
2g. Publishing Facilitator
Pooja Babrah, Paul Knapp
2h. Vocabulary Facilitator
Tim McNeil
2k. Conformance Facilitator
Pooja Babbrah
2m. Implementers
Humana, Cambia
3a. Project Scope
Develop a FHIR R4 based implementation guide for an API similar to the NCPDP Real-Time Pharmacy Benefit Check B2B standard that will allow consumers access to the same information as their providers including information related to their cash price. This information includes formulary and benefit information, OOP costs, therapeutic alternatives, and cash price through an API that would be accessible by the consumer through a third-party application.
3b. Project Need
The final Medicare Part D rule for 2020 (https://www.cms.gov/newsroom/fact-sheets/medicare-advantage-and-part-d-drug-pricing-final-rule-cms-4180-f#_Prohibition_Against_Gag) requires all Medicare Part D plans to send members information on lower cost therapeutic alternatives and requires the implementation of a real-time pharmacy benefit tool by 2021.
3c. Security Risk
No
3d. External Drivers
Final Medicare Part D rule for 2020
3e. Objectives/Deliverables and Target Dates
A FHIR R4 Implementation Guide
The desired ballot is January 2020.
Rough timeline
8/2019 - Draft implementation guide published
9/2019 - Connectathon
10/2019 - Development and Connectathon outcomes documented and presented to Pharmacy Work Group
11/2019 - Ballot material approved by Pharmacy Work Group
1/2020 - Ballot
3o. Earliest prior release and/or version to which the compatibility applies
None
4a. Products
FHIR Extensions, FHIR Profiles, FHIR Resources
4b. For FHIR IGs and FHIR Profiles, what product version(s) will the profiles apply to?
R4
4c. FHIR Profiles Version
R4
5a. Project Intent
Implementation Guide (IG) will be created/modified
5a. Is the project adopting/endorsing an externally developed IG?
No
5a. Specify external organization
CARIN Alliance
5b. Project Ballot Type
STU to Normative
5c. Additional Ballot Info
January 2020 is the desired ballot date.
5d. Joint Copyright
No
6a. External Project Collaboration
CARIN Alliance
6b. Content Already Developed
0%
6c. Content externally developed?
No
6e. Is this a hosted (externally funded) project?
Yes
6f. Stakeholders
Regulatory Agency, Standards Development Organizations (SDOs), Payors, Other
6f. Other Stakeholders
NCPDP, Consumer
6g. Vendors
Pharmaceutical, Health Care IT
6h. Providers
Healthcare Institutions (hospitals, long term care, home care, mental health)
6i. Realm
U.S. Realm Specific
7a. Management Group(s) to Review PSS
FHIR
7b. Sponsoring WG Approval Date
Jun 24, 2019
7c. Co-Sponsor Approval Date
Jul 02, 2019
7d. US Realm Approval Date
Jun 18, 2019
7f. FMG Approval Date
May 29, 2019
7i. Steering Division Approval Date
Jul 24, 2019
Version
2
Modifier
Anne Wizauer
Modify Date
Aug 19, 2019 15:28
1a. Project Name
PSS for CARIN Consumer-facing Real-time Pharmacy Benefit Check
1b. Project ID
1543
1c. Is Your Project an Investigative Project (aka PSS-Lite)?
No
1d. Is your Project Artifact now proceeding to Normative directly or after being either Informative or STU?
No
2a. Primary/Sponsor WG
Pharmacy
2b. Co-Sponsor WG
Health Care Devices
2c. Co-Sponsor Level of Involvement
Request formal content review prior to ballot
2c. Co-Sponsor Update Periods
Periodic updates between meetings during interim calls and at WGMs
2d. Project Facilitator
Pooja Babbrah, Ryan Howells
2g. Publishing Facilitator
Paul Knapp
2h. Vocabulary Facilitator
Tim McNeil
2k. Conformance Facilitator
Pooja Babbrah
2m. Implementers
Humana, Cambia
3a. Project Scope
Develop a FHIR R4 based implementation guide for an API similar to the NCPDP Real-Time Pharmacy Benefit Check B2B standard that will allow consumers access to the same information as their providers including information related to their cash price. This information includes formulary and benefit information, OOP costs, therapeutic alternatives, and cash price through an API that would be accessible by the consumer through a third-party application.
3b. Project Need
The final Medicare Part D rule for 2020 (https://www.cms.gov/newsroom/fact-sheets/medicare-advantage-and-part-d-drug-pricing-final-rule-cms-4180-f#_Prohibition_Against_Gag) requires all Medicare Part D plans to send members information on lower cost therapeutic alternatives and requires the implementation of a real-time pharmacy benefit tool by 2021.
3c. Security Risk
No
3d. External Drivers
Final Medicare Part D rule for 2020
3e. Objectives/Deliverables and Target Dates
A FHIR R4 Implementation Guide
The desired ballot is January 2020.
Rough timeline
8/2019 - Draft implementation guide published
9/2019 - Connectathon
10/2019 - Development and Connectathon outcomes documented and presented to Pharmacy Work Group
11/2019 - Ballot material approved by Pharmacy Work Group
1/2020 - Ballot
3o. Earliest prior release and/or version to which the compatibility applies
None
4a. Products
FHIR Extensions, FHIR Profiles, FHIR Resources
4b. For FHIR IGs and FHIR Profiles, what product version(s) will the profiles apply to?
R4
4c. FHIR Profiles Version
R4
5a. Project Intent
Implementation Guide (IG) will be created/modified
5a. Is the project adopting/endorsing an externally developed IG?
No
5a. Specify external organization
CARIN Alliance
5b. Project Ballot Type
STU to Normative
5c. Additional Ballot Info
January 2020 is the desired ballot date.
5d. Joint Copyright
No
6a. External Project Collaboration
CARIN Alliance
6b. Content Already Developed
0%
6c. Content externally developed?
No
6e. Is this a hosted (externally funded) project?
Yes
6f. Stakeholders
Regulatory Agency, Standards Development Organizations (SDOs), Payors, Other
6f. Other Stakeholders
NCPDP, Consumer
6g. Vendors
Pharmaceutical, Health Care IT
6h. Providers
Healthcare Institutions (hospitals, long term care, home care, mental health)
6i. Realm
U.S. Realm Specific
7a. Management Group(s) to Review PSS
FHIR
7b. Sponsoring WG Approval Date
Jun 24, 2019
7c. Co-Sponsor Approval Date
Jul 02, 2019
7d. US Realm Approval Date
Jun 18, 2019
7f. FMG Approval Date
May 29, 2019
7i. Steering Division Approval Date
Jul 24, 2019
Version
1
Modifier
Anne Wizauer
Modify Date
Aug 19, 2019 15:25
1a. Project Name
PSS for CARIN Consumer-facing Real-time Pharmacy Benefit Check
1b. Project ID
1543
1c. Is Your Project an Investigative Project (aka PSS-Lite)?
No
1d. Is your Project Artifact now proceeding to Normative directly or after being either Informative or STU?
No
2a. Primary/Sponsor WG
Pharmacy
2b. Co-Sponsor WG
Health Care Devices
2c. Co-Sponsor Level of Involvement
Request periodic project updates; specify period in text box below (e.g. 'Monthly', 'At WGMs', etc.)
2c. Co-Sponsor Update Periods
Periodic updates between meetings during interim calls and at WGMs
2d. Project Facilitator
Pooja Babbrah, Ryan Howells
2g. Publishing Facilitator
Paul Knapp
2h. Vocabulary Facilitator
Tim McNeil
2k. Conformance Facilitator
Pooja Babbrah
2m. Implementers
Humana, Cambia
3a. Project Scope
Develop a FHIR R4 based implementation guide for an API similar to the NCPDP Real-Time Pharmacy Benefit Check B2B standard that will allow consumers access to the same information as their providers including information related to their cash price. This information includes formulary and benefit information, OOP costs, therapeutic alternatives, and cash price through an API that would be accessible by the consumer through a third-party application.
3b. Project Need
The final Medicare Part D rule for 2020 (https://www.cms.gov/newsroom/fact-sheets/medicare-advantage-and-part-d-drug-pricing-final-rule-cms-4180-f#_Prohibition_Against_Gag) requires all Medicare Part D plans to send members information on lower cost therapeutic alternatives and requires the implementation of a real-time pharmacy benefit tool by 2021.
3c. Security Risk
No
3d. External Drivers
Final Medicare Part D rule for 2020
3e. Objectives/Deliverables and Target Dates
A FHIR R4 Implementation Guide
The desired ballot is January 2020.
Rough timeline
8/2019 - Draft implementation guide published
9/2019 - Connectathon
10/2019 - Development and Connectathon outcomes documented and presented to Pharmacy Work Group
11/2019 - Ballot material approved by Pharmacy Work Group
1/2020 - Ballot
It's not clear to me that NCPDP is directly involved in this project even though the scope basically says this work will be similar to an NCPDP API. HL7 has an SOU with NCPDP that covers joint work and joint copyrights.
Pharmacy WG has indicated that they would like to be the sponsor of this project given it seems to overlap with the daVinci Formulary Implementation Guide that Pharmacy owns.
Ryan HowellsPooja Babbrah In preparing this for TSC e-vote, I noticed that it is still missing the link to the HL7-managed project document repository in section 3.i. One you've got that entered, I will send it for their review.
10 Comments
Anne Wizauer
Ryan Howells Needs percentage of content externally developed, who developed the content, and cosponsor approval date.
Ryan Howells
Anne Wizauer Complete. Cosponsor approval date forthcoming.
Anne Wizauer
Thank you!
Austin Kreisler
It's not clear to me that NCPDP is directly involved in this project even though the scope basically says this work will be similar to an NCPDP API. HL7 has an SOU with NCPDP that covers joint work and joint copyrights.
Ryan Howells
They are involved and very supportive.
Brett Marquard
Is FM the right home for this project? How does it relate to CDS Hooks which enables real-time checks?
Melva Peters
Pharmacy WG has indicated that they would like to be the sponsor of this project given it seems to overlap with the daVinci Formulary Implementation Guide that Pharmacy owns.
Brett Marquard
Have you presented to Clinical Decision Support Work Group?
Anne Wizauer
Ryan Howells Pooja Babbrah In preparing this for TSC e-vote, I noticed that it is still missing the link to the HL7-managed project document repository in section 3.i. One you've got that entered, I will send it for their review.
Pooja Babbrah
Anne Wizauer - Section 3.i has been updated. Please let me know if you need anything else.